stockrowAxoGen, Inc.
AXGN Healthcare Medical Devices
AxoGen, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $225.2 million, up 20.2% from fiscal 2024.
- Revenue
- +26.2%
- EPS
- +163.2%
- Free cash flow
- +995.0%
- Total debt
- −73.1%
Quarter to September 2026, against a year earlier
Follow AXGN
Alert me
AxoGen, Inc. (AXGN) Price to free cash flow
As of 5 November 2026, AxoGen, Inc. (AXGN) trades at a price to free cash flow of 134×. Over the past ten years it has ranged from 0.0× (March 2026) to 80,911× (February 2025); the current reading is higher than 89% of that period. That is above the Medical Devices industry median of 28.8× and above the Healthcare sector median of 21.1×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 66,306× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 115× | (69.49%) |
| Jun 2026 | 378× | 69.58% |
| Mar 2026 | 223× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| ESTA Establishment Labs Holdings Inc. compare | n/m |
| ALMR Alamar Biosciences, Inc. compare | n/m |
| INSP Inspire Medical Systems, Inc. compare | 19.6× |
| UFPT UFP Technologies, Inc. compare | 37.5× |
| NEOG Neogen Corporation compare | 51.0× |
| ITGR Integer Holdings Corporation compare | 53.3× |
| TMDX TransMedics Group, Inc. compare | 53.5× |
| AXGN AxoGen, Inc. | 134× |
| IRTC iRhythm Holdings, Inc. compare | 584× |
| Medical Devices industry median | 28.8× |
| Healthcare sector median | 21.1× |
| Market median | 14.1× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on AXGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement